In response to last October’s FDA Patient-Focused Drug Development Guidance public workshop, we concluded our invited comment by raising the concern that the pharmaceutical clinical trial community would be limited to innovate unless we embrace high quality mixed methods patient centered outcomes research. We are, therefore, delighted to read that the FDA is creating a […]

ISOQOL’s annual conference will be a key milestone for us at Modus this year. Not only because 5 years ago the idea of Modus Outcomes came about after a meeting in Dublin and a Guinness or two, but also because we will be presenting our research! On Wednesday afternoon (October 24), Antoine will co-lead a workshop on a […]

This month saw the XXII World Congress of the International Measurement Confederation (IMEKO), a voluntary, non-governmental federation of 42 metrological organizations from all over the world. The conference was held in Belfast, UK and hosted by the Institute of Measurement and Control with support from the National Physical Laboratory. Its theme was ‘Knowledge Through Measurement’. Excitingly for the […]

On April 9th, in downtown New York City, we hosted our third ‘Patient-centered drug development: reflections, challenges & solutions’ workshop entitled: ‘Why we need to move to modern test theory: real world examples’. Once again, our roundtable event gathered a strong group of industry, academic and clinical representatives. Our external invited speakers included Professor Peter […]

We were very happy to have Farrah Pompilus represent Modus Outcomes at the inaugural FDA PFDD public workshop as an attendee in December 2017. It is encouraging to see that the FDA will be developing four guidance documents to further ensure greater patient-focused input throughout the regulatory process. We trust that these new documents will […]